[
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Pathogenic (2000-01-01)",
    "LastEvaluated": "2000-01-01",
    "AssertionReference": "N/A",
    "AssertionCriteria": "no assertion criteria provided",
    "Method": "literature only",
    "Condition": "BREAST CANCER, FAMILIAL",
    "AffectedStatus": "not provided",
    "AlleleOrigin": "germline:human",
    "Submitter": "OMIM",
    "SubmitterAccession": "SCV000034254.1",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2013-04-04",
    "Comment": "In studies of 20 patients from breast cancer (114480) families and 25 patients with breast cancer that was early-onset, bilateral, or accompanied by a history of primary cancer(s) of other organs, Kato et al. (2000) found a missense mutation in 2 patients with familial breast cancer: a G-to-A transition converting codon 150 from CGG (arg) to CAG (gln). Both patients had bilateral breast cancer, one with synchronous bilateral breast cancer and the other with synchronous bilateral multiple breast cancer. The patients were presumed to be unrelated."
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Benign (2020-10-28)",
    "LastEvaluated": "2020-10-28",
    "AssertionReference": "Choudhury A et al. (Nature 2020) (PMID: 33116287)",
    "AssertionCriteria": "criteria provided, single submitter",
    "Method": "research",
    "Condition": "not specified",
    "AffectedStatus": "unknown",
    "AlleleOrigin": "germline:[object Object]",
    "Submitter": "H3Africa Consortium",
    "SubmitterAccession": "SCV002014656.1",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2021-11-13",
    "Comment": "While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.052, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error."
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Benign (2024-01-25)",
    "LastEvaluated": "2024-01-25",
    "AssertionReference": "Invitae Variant Classification Sherloc (09022015) (PMID: 28492532)",
    "AssertionCriteria": "criteria provided, single submitter",
    "Method": "clinical testing",
    "Condition": "N/A",
    "AffectedStatus": "unknown",
    "AlleleOrigin": "germline:[object Object]",
    "Submitter": "Labcorp Genetics (formerly Invitae), Labcorp",
    "SubmitterAccession": "SCV001032711.4",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2024-02-20",
    "Comment": "-"
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Uncertain significance (2024-05-07)",
    "LastEvaluated": "2024-05-07",
    "AssertionReference": "GeneDx Variant Classification Process June 2021",
    "AssertionCriteria": "criteria provided, single submitter",
    "Method": "clinical testing",
    "Condition": "Not Provided",
    "AffectedStatus": "yes",
    "AlleleOrigin": "germline:[object Object]",
    "Submitter": "GeneDx",
    "SubmitterAccession": "SCV002032718.3",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2024-07-23",
    "Comment": "Observed in individuals with breast cancer but also in controls (PMID: 10807537, 23300655, 28864920, 32019277); Published functional studies are inconclusive: retention of polymer formation, decreased single strand and double strand DNA binding activities, and conflicting ATP-hydrolyzing activity (PMID: 17666788, 25539919); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 17666788, 10807537, 25539919, 23300655, 28864920, 27153395, 16762046, 32019277, 30271574, 31589614, 35534704, 35273153)"
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Likely benign (2018-03-06)",
    "LastEvaluated": "2018-03-06",
    "AssertionReference": "ACMG Guidelines, 2015 (PMID: 25741868)",
    "AssertionCriteria": "criteria provided, single submitter",
    "Method": "clinical testing",
    "Condition": "not specified",
    "AffectedStatus": "no",
    "AlleleOrigin": "germline:[object Object]",
    "Submitter": "Genetic Services Laboratory, University of Chicago",
    "SubmitterAccession": "SCV002069109.1",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2022-01-29",
    "Comment": "-"
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Likely benign (2024-01-23)",
    "LastEvaluated": "2024-01-23",
    "AssertionReference": "ACMG Guidelines, 2015 (PMID: 25741868)",
    "AssertionCriteria": "criteria provided, single submitter",
    "Method": "clinical testing",
    "Condition": "N/A",
    "AffectedStatus": "unknown",
    "AlleleOrigin": "unknown:[object Object]",
    "Submitter": "Mendelics",
    "SubmitterAccession": "SCV001139555.2",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2024-02-04",
    "Comment": "-"
  },
  {
    "SearchTerm": "",
    "TranscriptID": "NM_002875.5",
    "GeneSymbol": "RAD51",
    "DNAChange": "c.449G>A",
    "ProteinChange": "p.Arg150Gln",
    "GeneName": "",
    "AlleleName": "NM_002875.5(RAD51):c.449G>A (p.Arg150Gln)",
    "VariationID": 13127,
    "AccessionID": "VCV000013127",
    "Classification": "Likely benign (2020-04-14)",
    "LastEvaluated": "2020-04-14",
    "AssertionReference": "N/A",
    "AssertionCriteria": "no assertion criteria provided",
    "Method": "clinical testing",
    "Condition": "RAD51-related condition",
    "AffectedStatus": "unknown",
    "AlleleOrigin": "germline:[object Object]",
    "Submitter": "PreventionGenetics, part of Exact Sciences",
    "SubmitterAccession": "SCV004761412.2",
    "FirstInClinVar": "2013-04-04",
    "MostRecentSubmission": "2024-11-25",
    "LastUpdated": "2024-10-08",
    "Comment": "This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications)."
  }
]